Formative Research on HPV Vaccine Acceptance among Health Workers, Teachers, Parents, and Social Influencers in Uzbekistan
Author:
Warsi Sahil Khan1ORCID, Nielsen Siff Malue2, Franklin Barbara A. K.3, Abdullaev Shukhrat4, Ruzmetova Dilfuza4, Raimjanov Ravshan4, Nagiyeva Khalida4, Safaeva Kamola5
Affiliation:
1. Consultant, World Health Organization Regional Office for Europe, DK-2100 Copenhagen Ø, Denmark 2. Vaccine-Preventable Diseases and Immunization Programme, World Health Organization Regional Office for Europe, DK-2100 Copenhagen Ø, Denmark 3. All One Communication, San Diego, CA 92117, USA 4. ITA FACT 5. World Health Organization Country Office in Uzbekistan, Tashkent 100100, Uzbekistan
Abstract
Human papillomavirus (HPV) vaccines effectively prevent cervical cancer, most of which results from undetected long-term HPV infection. HPV vaccine introduction is particularly sensitive and complicated given widespread misinformation and vaccination of young girls before their sexual debut. Research has examined HPV vaccine introduction in lower- and middle-income countries (LMICs), but almost no studies attend to HPV vaccine attitudes in central Asian countries. This article describes the results of a qualitative formative research study to develop an HPV vaccine introduction communication plan in Uzbekistan. Data collection and analysis were designed using the Capability, Opportunity, and Motivation for Behaviour change (COM-B) mode for understanding health behaviours. This research was carried out with health workers, parents, grandparents, teachers, and other social influencers in urban, semi-urban, and rural sites. Information was collected using focus group discussions (FGDs) and semi-structured in-depth interviews (IDIs), and data in the form of participants’ words, statements, and ideas were thematically analysed to identify COM-B barriers and drivers for each target group’s HPV vaccine-related behaviour. Represented through exemplary quotations, findings were used to inform the development of the HPV vaccine introduction communication plan. Capability findings indicated that participants understood cervical cancer was a national health issue, but HPV and HPV vaccine knowledge was limited among non-health professionals, some nurses, and rural health workers. Results on an opportunity for accepting the HPV vaccine showed most participants would do so if they had access to credible information on vaccine safety and evidence. Regarding motivation, all participant groups voiced concern about the potential effects on young girls’ future fertility. Echoing global research, the study results highlighted that trust in health workers and the government as health-related information sources and collaboration among schools, municipalities, and polyclinics could support potential vaccine acceptance and uptake. Resource constraints precluded including vaccine target-aged girls in research and additional field sites. Participants represented diverse social and economic backgrounds reflective of the country context, and the communication plan developed using research insights contributed to the Ministry of Health (MoH) of the Republic of Uzbekistan HPV vaccine introduction efforts that saw high first dose uptake.
Funder
WHO Country Office in Uzbekistan
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference53 articles.
1. WHO (2020). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem, WHO. 2. WHO (2017). Human Papillomavirus Vaccines: WHO Position Paper, May 2017. Wkly. Epidemiol. Rec., 92, 241–268. 3. Bruni, L., Albero, G., Serrano, B., Mena, M., Gómez, D., Muñoz, J., Bosch, F., and Sanjosé, S. (2019). Human Papillomavirus and Related Diseases Report: Uzbekistan, HPV Information Centre. 4. The Estimated Mortality Impact of Vaccinations Forecast to Be Administered during 2011–2020 in 73 Countries Supported by the GAVI Alliance;Lee;Vaccine,2013 5. WHO (2017). HPV Vaccine Communication. Special Considerations for a Unique Vaccine, 2016 Update. (WHO/IVB/17.02), World Health Organization.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|